Genomic sequencing from the Framingham Heart Study Offspring cohort surprisingly revealed that patients with ROMK loss-of-function polymorphisms (R193P, H251Y, T313FS, P166S, and R169H) are less susceptible to hypertension. Here, KCNJ1 is linked to hypertensive disorder.